More articles from Review
- Hepatitis C virus: Prevention, screening, and interpretation of assays
Patients at risk of hepatitis C virus infection should be screened for it so that they can be treated and potentially cured, or can at least avoid transmitting the disease to others.
- Interferon-gamma-release assays: Better than tuberculin skin testing?
These new blood tests overcome some of the limitations of skin testing, but converting to them poses challenges.
Charcot neuroarthropathy: An often overlooked complication of diabetesSuspect this condition if a patient with long-standing, poorly controlled diabetes and peripheral neuropathy develops a red, hot, swollen foot without ulceration.
- Coronary heart disease in people infected with HIV
Traditional risk factors are the main culprits, although the infection itself and antiviral therapy also contribute.
Noninvasive tests for liver disease, fibrosis, and cirrhosis: Is liver biopsy obsolete?The need for liver biopsy is diminishing, thanks to accurate blood tests and imaging studies.
- How to prevent glucocorticoid-induced osteoporosis
When prescribing glucocorticoids for long-term treatment, physicians should take steps to prevent osteoporosis.
- Menstrual manipulation: Options for suppressing the cycle
If they wish, women can have more control over when and if they menstruate, even though myths and misperceptions abound among clinicians.
- Pharmacoresistant epilepsy: From pathogenesis to current and emerging therapies
Almost one-third of people with epilepsy continue to have seizures despite appropriate treatment. We recommend early referral to an epilepsy center.
Bariatric surgery for type 2 diabetes: Weighing the impact for obese patientsBariatric surgery results in remission of diabetes in most patients. Why should this be?
- Incidence, outcomes, and management of bleeding in non-ST-elevation acute coronary syndromes
Powerful antithrombotic and antiplatelet drugs and percutaneous interventions pose risks of bleeding. Fortunately, the risk can be managed.